TVTX
#1191
Travere Therapeutics, Inc. - Common Stock
65.5 9 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.12%
Variación mensual
+19.65%
Variación en los últimos 6 meses
+124.01%
Cambio anual
+127.98%
Cierres anteriores
65.6 7
Open
65.5 6
Mínimo
65.5 1
Máximo
65.7 9
Volumen
131
Financials
- Market Capitalization 6.18 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-126.24
Relación precio/flujo de caja
9.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1117 |  SRRK Scholar Rock Holding Corporation - Common Stock | 56.71 USD | -1.89% | -2.02% | +19.52% | +88.91% | 6.91 B USD | ||
| 1184 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 97.12 USD | -0.35% | +0.33% | -7.76% | +38.49% | 6.31 B USD | ||
| 1213 |  ERAS Erasca, Inc. - Common Stock | 17.25 USD | -4.33% | -0.98% | -2.87% | +1005.77% | 6.03 B USD | ||
| 1220 |  LQDA Liquidia Corporation - Common Stock | 66.93 USD | -1.12% | -5.27% | -18.59% | +196.15% | 5.99 B USD |